Stratec SE (ETR:SBS)
Germany
· Delayed Price · Currency is EUR 17.62
-0.38 (-2.11%)
Apr 29, 2026, 5:35 PM CET
Stratec SE Company Description
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally.
The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers.
It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software.
The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Stratec SE
| Country | Germany |
| Founded | 1979 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,420 |
| CEO | Marcus Wolfinger |
Contact Details
Address: Gewerbestrasse 37 Birkenfeld, 75217 Germany | |
| Phone | 49 7082 7916 0 |
| Website | stratec.com |
Stock Details
| Ticker Symbol | SBS |
| Exchange | Deutsche Börse Xetra |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | DE000STRA555 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Marcus Wolfinger | Chairman of Board of Management and Chief Executive Officer |
| Dr. Claus Vielsack | Director of Product Development and Member of Board of Management |
| Dr. Georg Bauer | Director for Sales and Member of Management Board |
| Hermann Leistner | Founder and Advisor |
| Tanja Bucherl | Chief Financial Officer and Member of Management Board |
| Jan Keppeler | Head of Investor Relations, Sustainability and Corporate Communications |